WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Stock Short Interest Report for October

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) was the target of a significant increase in short interest during the month of October. As of October 30th, there was short interest totaling 66,851 shares, an increase of 498.5% from the October 15th total of 11,170 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily trading volume, of 117,526 shares, the short-interest ratio is currently 0.6 days.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised shares of WuXi Biologics (Cayman) to a “hold” rating in a research note on Friday, August 28th. One analyst has rated the stock with a Hold rating. Based on data from MarketBeat, WuXi Biologics (Cayman) presently has an average rating of “Hold”.

WuXi Biologics (Cayman) Stock Down 1.0%

OTCMKTS:WXXWY traded down $0.12 during mid-day trading on Wednesday, reaching $12.32. The company’s stock had a trading volume of 11,685 shares, compared to its average volume of 69,463. The company’s fifty day simple moving average is $12.77 and its two-hundred day simple moving average is $10.27. WuXi Biologics has a twelve month low of $7.30 and a twelve month high of $14.80.

WuXi Biologics (Cayman) Company Profile

WuXi Biologics (Cayman) Inc. is a contract research, development and manufacturing organization focused on biologic medicines. Founded in 2010, the company provides services to biotechnology and pharmaceutical companies developing treatments for patients worldwide. Its services span the biologics development process, including discovery, cell-line and process development, analytical testing, and clinical and commercial manufacturing. The company works with products such as monoclonal and multispecific antibodies, recombinant proteins, and antibody-drug conjugates.